GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Frequently asked questions
What sector does GlucoTrack Inc (GCTK) operate in?
GlucoTrack Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is GlucoTrack Inc (GCTK) current stock price?
As of the latest data, GlucoTrack Inc stock price is $1.39, with a previous close of $1.61. GlucoTrack Inc lost -$0.22 in the last trading session, representing a -13.66% loss.
What is GlucoTrack Inc (GCTK) current market capitalization?
GlucoTrack Inc market cap is approximately 1.11 million.
What is GlucoTrack Inc (GCTK) Earnings Per Share (EPS)?
The trailing EPS is $17.25.
What is GlucoTrack Inc (GCTK) Price-to-Earnings (P/E) ratio?
GlucoTrack Inc current P/E ratio is 0.08.
What is GlucoTrack Inc (GCTK) EBITDA?
GlucoTrack Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.79 million.
Does GlucoTrack Inc (GCTK) pay dividends?
No. GlucoTrack Inc does not pay a dividend.
What is GlucoTrack Inc (GCTK) beta (volatility) score?
GlucoTrack Inc has a beta of 0.664, indicating lower volatility than the overall market.